Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the ...

KBC Group NV grew its holdings in shares of Sweetgreen, Inc. (NYSE:SG – Free Report) by 65.0% during the fourth quarter, ...

Seeing “growth on hiatus,” Mr. Bir reduced his own forecast for 2025 and 2026 “with revisions mainly for longer lease-up ...

Barry McCarthy emphasized progress in Deluxe's North Star program, which aims to increase annualized adjusted EBITDA by $80 million and free cash flows by $100 million by 2026. He noted that 80% of ...

TD Cowen exhibited confidence in Avepoint Inc. (NASDAQ:AVPT), as the firm's analyst J. Derrick Wood increased the price target for the company's stock to $20.00, up from the previous $15.00, while ...

Shares of Sweetgreen, Inc. (NYSE:SG – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from ...

TD Cowen analyst Max Rakhlenko has maintained their bullish stance on BOOT stock, giving a Buy rating today.Invest with Confidence: Follow ...

TD Cowen analyst Max Rakhlenko has maintained their neutral stance on TSCO stock, giving a Hold rating on January 28.Invest with Confidence: ...

Seidl also noted that C.H. Robinson is continuing to invest in technology initiatives aimed at fostering a more efficient operating model for the long term. These initiatives are in line with the ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...